Tradestie Institutional Equity Comparison Engine

PLSE vs EKSO โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

PLSE Overall Edge

PLSE Captures Institutional Edge (3โ€“0 Pillars ยท 5โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Pulse Biosciences, Inc Common Stock (DE) (PLSE) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, PLSE trades at N/M Forward P/E with -5861.2% operating margin (+359.3% YoY revenue) versus EKSO at N/M Forward P/E and -119.7% operating margin (-38.3% YoY). In options structure, PLSE sits in CONSOLIDATION (10th %ile IV; Dealer Gamma Walls on Pro) against EKSO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
PLSE N/M vs EKSO N/M Fwd P/E
Growth & Margin Winner PLSE
Op Margin -5861.2% vs -119.7% ยท YoY +359.3% vs -38.3%
Momentum & Technical Winner PLSE
1Y +250.1% vs +62.6% ยท 52W Pos 71% vs 87%
Options & Structure Winner PLSE
CONSOLIDATION (10th %ile IV) vs UNCLASSIFIED (N/A IV)
PLSE NASDAQ
Pulse Biosciences, Inc Common Stock (DE)
Surgical & Medical Instruments & Apparatus
$45.55
+2.57% 1D
Market Cap $3.3B
1M Return -13.53%
1Y Return +250.12%
Forward P/E N/M
Unified AI Score
64.2 / 100 BUY
Tech 63.0 Fund 60.0 Flow 65.0 Mom 50.0
EKSO NASDAQ
Ekso Bionics Holdings, Inc. Common Stock
General Industrial Machinery & Equipment, Nec
$11.80
+0.08% 1D
Market Cap $42.0M
1M Return +25.53%
1Y Return +62.6%
Forward P/E N/M
Unified AI Score
58.1 / 100 HOLD
Tech 60.0 Fund 54.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: PLSE +250.12% EKSO +62.6% Spread: +138.84 pp (EKSO Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
PLSE TTM Op. Margin: -5861.2% EKSO TTM Op. Margin: -119.7%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on PLSE vs EKSO. Trailing 12-month operating profitability (PLSE -5861.2% vs EKSO -119.7%) and valuation multiples (PLSE N/M vs EKSO N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: PLSE (5) vs EKSO (2)
Institutional Metric PLSE EKSO Criterion Row Winner
Market Capitalization Scale $3.3B $42.0M Larger Scale PLSE
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +359.3% -38.3% Higher Growth PLSE
Operating Margin (TTM) Profitability -5861.2% -119.7% Higher Margin EKSO
Net Profit Margin Profitability 0.0% -91.4% Higher Margin PLSE
Return on Equity (ROE) Capital Efficiency -60.6% -107.6% Higher ROE PLSE
52-Week Range Position Momentum 71% ($13โ€“$59) 87% ($0โ€“$14) Stronger Trend EKSO
Beta / 30D Volatility Risk Regime 1.71ฮฒ ยท 76% Vol 2.16ฮฒ ยท 76% Vol Lower Realized Risk Tie
Unified Institutional Score Composite Signal 64.2 / 100 (BUY) 58.1 / 100 (HOLD) Higher Composite PLSE

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full PLSE vs EKSO Buy Guide
PLSE CONSOLIDATION
55d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 10th %ile
IV Regime Compressed (<25th %ile)
Live PLSE Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
EKSO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live EKSO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither PLSE nor EKSO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.